The global Personalized Cancer Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Personalized Cancer Vaccines are the type of immunotherapy that boosts the immune system to fight against a cancerous cell. These types of vaccine are tailored to match a patients particular tumor cell after received cancer related surgery. This vaccine may prevent from cancer, destroy cancer cells and inhibit the growth of tumors cells.
This report aims to provide a comprehensive presentation of the global market for Personalized Cancer Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Cancer Vaccines. This report contains market size and forecasts of Personalized Cancer Vaccines in global, including the following market information:
Global Personalized Cancer Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
By Cancer Type Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Personalized Cancer Vaccines include Advaxis Inc, Personalis, Hoffmann-La Roche Ltd, BioNtech, Celldex, CureVac AG, Genetech, Genocea and Gritstone Oncology, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Personalized Cancer Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Personalized Cancer Vaccines Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Personalized Cancer Vaccines Market Segment Percentages, by Type, 2022 (%)
- By Cancer Type
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Leukemia
- Prostate Cancer
- Cervical Cancer
- Glioblastoma
- Others
- By Mechanism of Action Type
- Tumor-associated antigens (TAAs)
- Tumor-specific antigens (TSAs)
- Somatic Mutations in Cancer Pharmacogenomics
- Pharmacogenomics towards Genomic Polymorphism
Global Personalized Cancer Vaccines Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Personalized Cancer Vaccines Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Homecare
- Specialty Clinics
- Others
Global Personalized Cancer Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Personalized Cancer Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Personalized Cancer Vaccines revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Personalized Cancer Vaccines revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Advaxis Inc
- Personalis
- Hoffmann-La Roche Ltd
- BioNtech
- Celldex
- CureVac AG
- Genetech
- Genocea
- Gritstone Oncology
- ISA Pharmaceuticals
- Merck
- Moderna Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Personalized Cancer Vaccines, market overview.
Chapter 2: Global Personalized Cancer Vaccines market size in revenue.
Chapter 3: Detailed analysis of Personalized Cancer Vaccines company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments
by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments
by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Personalized Cancer Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Personalized Cancer Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Personalized Cancer Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Personalized Cancer Vaccines Overall Market Size
2.1 Global Personalized Cancer Vaccines Market Size: 2022 VS 2029
2.2 Global Personalized Cancer Vaccines Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Personalized Cancer Vaccines Players in Global Market
3.2 Top Global Personalized Cancer Vaccines Companies Ranked by Revenue
3.3 Global Personalized Cancer Vaccines Revenue by Companies
3.4 Top 3 and Top 5 Personalized Cancer Vaccines Companies in Global Market, by Revenue in 2022
3.5 Global Companies Personalized Cancer Vaccines Product Type
3.6 Tier 1, Tier 2 and Tier 3 Personalized Cancer Vaccines Players in Global Market
3.6.1 List of Global Tier 1 Personalized Cancer Vaccines Companies
3.6.2 List of Global Tier 2 and Tier 3 Personalized Cancer Vaccines Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Personalized Cancer Vaccines Market Size Markets, 2022 & 2029
4.1.2 Lung Cancer
4.1.3 Breast Cancer
4.1.4 Colorectal Cancer
4.1.5 Leukemia
4.1.6 Prostate Cancer
4.1.7 Cervical Cancer
4.1.8 Glioblastoma
4.1.9 Others
4.2 By Type - Global Personalized Cancer Vaccines Revenue & Forecasts
4.2.1 By Type - Global Personalized Cancer Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Personalized Cancer Vaccines Revenue, 2024-2029
4.2.3 By Type - Global Personalized Cancer Vaccines Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Personalized Cancer Vaccines Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Homecare
5.1.4 Specialty Clinics
5.1.5 Others
5.2 By Application - Global Personalized Cancer Vaccines Revenue & Forecasts
5.2.1 By Application - Global Personalized Cancer Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Personalized Cancer Vaccines Revenue, 2024-2029
5.2.3 By Application - Global Personalized Cancer Vaccines Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Personalized Cancer Vaccines Market Size, 2022 & 2029
6.2 By Region - Global Personalized Cancer Vaccines Revenue & Forecasts
6.2.1 By Region - Global Personalized Cancer Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Personalized Cancer Vaccines Revenue, 2024-2029
6.2.3 By Region - Global Personalized Cancer Vaccines Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Personalized Cancer Vaccines Revenue, 2018-2029
6.3.2 US Personalized Cancer Vaccines Market Size, 2018-2029
6.3.3 Canada Personalized Cancer Vaccines Market Size, 2018-2029
6.3.4 Mexico Personalized Cancer Vaccines Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Personalized Cancer Vaccines Revenue, 2018-2029
6.4.2 Germany Personalized Cancer Vaccines Market Size, 2018-2029
6.4.3 France Personalized Cancer Vaccines Market Size, 2018-2029
6.4.4 U.K. Personalized Cancer Vaccines Market Size, 2018-2029
6.4.5 Italy Personalized Cancer Vaccines Market Size, 2018-2029
6.4.6 Russia Personalized Cancer Vaccines Market Size, 2018-2029
6.4.7 Nordic Countries Personalized Cancer Vaccines Market Size, 2018-2029
6.4.8 Benelux Personalized Cancer Vaccines Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Personalized Cancer Vaccines Revenue, 2018-2029
6.5.2 China Personalized Cancer Vaccines Market Size, 2018-2029
6.5.3 Japan Personalized Cancer Vaccines Market Size, 2018-2029
6.5.4 South Korea Personalized Cancer Vaccines Market Size, 2018-2029
6.5.5 Southeast Asia Personalized Cancer Vaccines Market Size, 2018-2029
6.5.6 India Personalized Cancer Vaccines Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Personalized Cancer Vaccines Revenue, 2018-2029
6.6.2 Brazil Personalized Cancer Vaccines Market Size, 2018-2029
6.6.3 Argentina Personalized Cancer Vaccines Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Personalized Cancer Vaccines Revenue, 2018-2029
6.7.2 Turkey Personalized Cancer Vaccines Market Size, 2018-2029
6.7.3 Israel Personalized Cancer Vaccines Market Size, 2018-2029
6.7.4 Saudi Arabia Personalized Cancer Vaccines Market Size, 2018-2029
6.7.5 UAE Personalized Cancer Vaccines Market Size, 2018-2029
7 Personalized Cancer Vaccines Companies Profiles
7.1 Advaxis Inc
7.1.1 Advaxis Inc Company Summary
7.1.2 Advaxis Inc Business Overview
7.1.3 Advaxis Inc Personalized Cancer Vaccines Major Product Offerings
7.1.4 Advaxis Inc Personalized Cancer Vaccines Revenue in Global Market (2018-2023)
7.1.5 Advaxis Inc Key News & Latest Developments
7.2 Personalis
7.2.1 Personalis Company Summary
7.2.2 Personalis Business Overview
7.2.3 Personalis Personalized Cancer Vaccines Major Product Offerings
7.2.4 Personalis Personalized Cancer Vaccines Revenue in Global Market (2018-2023)
7.2.5 Personalis Key News & Latest Developments
7.3 Hoffmann-La Roche Ltd
7.3.1 Hoffmann-La Roche Ltd Company Summary
7.3.2 Hoffmann-La Roche Ltd Business Overview
7.3.3 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Major Product Offerings
7.3.4 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Revenue in Global Market (2018-2023)
7.3.5 Hoffmann-La Roche Ltd Key News & Latest Developments
7.4 BioNtech
7.4.1 BioNtech Company Summary
7.4.2 BioNtech Business Overview
7.4.3 BioNtech Personalized Cancer Vaccines Major Product Offerings
7.4.4 BioNtech Personalized Cancer Vaccines Revenue in Global Market (2018-2023)
7.4.5 BioNtech Key News & Latest Developments
7.5 Celldex
7.5.1 Celldex Company Summary
7.5.2 Celldex Business Overview
7.5.3 Celldex Personalized Cancer Vaccines Major Product Offerings
7.5.4 Celldex Personalized Cancer Vaccines Revenue in Global Market (2018-2023)
7.5.5 Celldex Key News & Latest Developments
7.6 CureVac AG
7.6.1 CureVac AG Company Summary
7.6.2 CureVac AG Business Overview
7.6.3 CureVac AG Personalized Cancer Vaccines Major Product Offerings
7.6.4 CureVac AG Personalized Cancer Vaccines Revenue in Global Market (2018-2023)
7.6.5 CureVac AG Key News & Latest Developments
7.7 Genetech
7.7.1 Genetech Company Summary
7.7.2 Genetech Business Overview
7.7.3 Genetech Personalized Cancer Vaccines Major Product Offerings
7.7.4 Genetech Personalized Cancer Vaccines Revenue in Global Market (2018-2023)
7.7.5 Genetech Key News & Latest Developments
7.8 Genocea
7.8.1 Genocea Company Summary
7.8.2 Genocea Business Overview
7.8.3 Genocea Personalized Cancer Vaccines Major Product Offerings
7.8.4 Genocea Personalized Cancer Vaccines Revenue in Global Market (2018-2023)
7.8.5 Genocea Key News & Latest Developments
7.9 Gritstone Oncology
7.9.1 Gritstone Oncology Company Summary
7.9.2 Gritstone Oncology Business Overview
7.9.3 Gritstone Oncology Personalized Cancer Vaccines Major Product Offerings
7.9.4 Gritstone Oncology Personalized Cancer Vaccines Revenue in Global Market (2018-2023)
7.9.5 Gritstone Oncology Key News & Latest Developments
7.10 ISA Pharmaceuticals
7.10.1 ISA Pharmaceuticals Company Summary
7.10.2 ISA Pharmaceuticals Business Overview
7.10.3 ISA Pharmaceuticals Personalized Cancer Vaccines Major Product Offerings
7.10.4 ISA Pharmaceuticals Personalized Cancer Vaccines Revenue in Global Market (2018-2023)
7.10.5 ISA Pharmaceuticals Key News & Latest Developments
7.11 Merck
7.11.1 Merck Company Summary
7.11.2 Merck Business Overview
7.11.3 Merck Personalized Cancer Vaccines Major Product Offerings
7.11.4 Merck Personalized Cancer Vaccines Revenue in Global Market (2018-2023)
7.11.5 Merck Key News & Latest Developments
7.12 Moderna Therapeutics
7.12.1 Moderna Therapeutics Company Summary
7.12.2 Moderna Therapeutics Business Overview
7.12.3 Moderna Therapeutics Personalized Cancer Vaccines Major Product Offerings
7.12.4 Moderna Therapeutics Personalized Cancer Vaccines Revenue in Global Market (2018-2023)
7.12.5 Moderna Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Personalized Cancer Vaccines Market Opportunities & Trends in Global Market
Table 2. Personalized Cancer Vaccines Market Drivers in Global Market
Table 3. Personalized Cancer Vaccines Market Restraints in Global Market
Table 4. Key Players of Personalized Cancer Vaccines in Global Market
Table 5. Top Personalized Cancer Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Personalized Cancer Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Personalized Cancer Vaccines Revenue Share by Companies, 2018-2023
Table 8. Global Companies Personalized Cancer Vaccines Product Type
Table 9. List of Global Tier 1 Personalized Cancer Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Personalized Cancer Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Personalized Cancer Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Personalized Cancer Vaccines Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Personalized Cancer Vaccines Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Personalized Cancer Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Personalized Cancer Vaccines Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Personalized Cancer Vaccines Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Personalized Cancer Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Personalized Cancer Vaccines Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Personalized Cancer Vaccines Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Personalized Cancer Vaccines Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Personalized Cancer Vaccines Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Personalized Cancer Vaccines Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Personalized Cancer Vaccines Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Personalized Cancer Vaccines Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Personalized Cancer Vaccines Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Personalized Cancer Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Personalized Cancer Vaccines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Personalized Cancer Vaccines Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Personalized Cancer Vaccines Revenue, (US$, Mn), 2024-2029
Table 30. Advaxis Inc Company Summary
Table 31. Advaxis Inc Personalized Cancer Vaccines Product Offerings
Table 32. Advaxis Inc Personalized Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 33. Advaxis Inc Key News & Latest Developments
Table 34. Personalis Company Summary
Table 35. Personalis Personalized Cancer Vaccines Product Offerings
Table 36. Personalis Personalized Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 37. Personalis Key News & Latest Developments
Table 38. Hoffmann-La Roche Ltd Company Summary
Table 39. Hoffmann-La Roche Ltd Personalized Cancer Vaccines Product Offerings
Table 40. Hoffmann-La Roche Ltd Personalized Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 41. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 42. BioNtech Company Summary
Table 43. BioNtech Personalized Cancer Vaccines Product Offerings
Table 44. BioNtech Personalized Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 45. BioNtech Key News & Latest Developments
Table 46. Celldex Company Summary
Table 47. Celldex Personalized Cancer Vaccines Product Offerings
Table 48. Celldex Personalized Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 49. Celldex Key News & Latest Developments
Table 50. CureVac AG Company Summary
Table 51. CureVac AG Personalized Cancer Vaccines Product Offerings
Table 52. CureVac AG Personalized Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 53. CureVac AG Key News & Latest Developments
Table 54. Genetech Company Summary
Table 55. Genetech Personalized Cancer Vaccines Product Offerings
Table 56. Genetech Personalized Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 57. Genetech Key News & Latest Developments
Table 58. Genocea Company Summary
Table 59. Genocea Personalized Cancer Vaccines Product Offerings
Table 60. Genocea Personalized Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 61. Genocea Key News & Latest Developments
Table 62. Gritstone Oncology Company Summary
Table 63. Gritstone Oncology Personalized Cancer Vaccines Product Offerings
Table 64. Gritstone Oncology Personalized Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 65. Gritstone Oncology Key News & Latest Developments
Table 66. ISA Pharmaceuticals Company Summary
Table 67. ISA Pharmaceuticals Personalized Cancer Vaccines Product Offerings
Table 68. ISA Pharmaceuticals Personalized Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 69. ISA Pharmaceuticals Key News & Latest Developments
Table 70. Merck Company Summary
Table 71. Merck Personalized Cancer Vaccines Product Offerings
Table 72. Merck Personalized Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 73. Merck Key News & Latest Developments
Table 74. Moderna Therapeutics Company Summary
Table 75. Moderna Therapeutics Personalized Cancer Vaccines Product Offerings
Table 76. Moderna Therapeutics Personalized Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 77. Moderna Therapeutics Key News & Latest Developments
List of Figures
Figure 1. Personalized Cancer Vaccines Segment by Type in 2022
Figure 2. Personalized Cancer Vaccines Segment by Application in 2022
Figure 3. Global Personalized Cancer Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Personalized Cancer Vaccines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Personalized Cancer Vaccines Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Personalized Cancer Vaccines Revenue in 2022
Figure 8. By Type - Global Personalized Cancer Vaccines Revenue Market Share, 2018-2029
Figure 9. By Application - Global Personalized Cancer Vaccines Revenue Market Share, 2018-2029
Figure 10. By Type - Global Personalized Cancer Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Personalized Cancer Vaccines Revenue Market Share, 2018-2029
Figure 12. By Application - Global Personalized Cancer Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Personalized Cancer Vaccines Revenue Market Share, 2018-2029
Figure 14. By Region - Global Personalized Cancer Vaccines Revenue Market Share, 2018-2029
Figure 15. By Country - North America Personalized Cancer Vaccines Revenue Market Share, 2018-2029
Figure 16. US Personalized Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Personalized Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Personalized Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Personalized Cancer Vaccines Revenue Market Share, 2018-2029
Figure 20. Germany Personalized Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 21. France Personalized Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Personalized Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Personalized Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Personalized Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Personalized Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Personalized Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Personalized Cancer Vaccines Revenue Market Share, 2018-2029
Figure 28. China Personalized Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Personalized Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Personalized Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Personalized Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 32. India Personalized Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Personalized Cancer Vaccines Revenue Market Share, 2018-2029
Figure 34. Brazil Personalized Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Personalized Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Personalized Cancer Vaccines Revenue Market Share, 2018-2029
Figure 37. Turkey Personalized Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Personalized Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Personalized Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Personalized Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 41. Advaxis Inc Personalized Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Personalis Personalized Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Hoffmann-La Roche Ltd Personalized Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. BioNtech Personalized Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Celldex Personalized Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. CureVac AG Personalized Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Genetech Personalized Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Genocea Personalized Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Gritstone Oncology Personalized Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. ISA Pharmaceuticals Personalized Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Merck Personalized Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Moderna Therapeutics Personalized Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
